12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

• Eargo EAR shares rose 10.9% to $5.29 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 93.1K shares, which is 2.6 percent of its average volume over the last 100 days. The company's market cap stands at $207.7 million.
• Immix Biopharma IMMX shares increased by 6.01% to $2.82. The market value of their outstanding shares is at $21.3 million.
• Genfit GNFT shares increased by 5.86% to $4.15. The company's market cap stands at $206.3 million.
• Qualigen Therapeutics QLGN stock increased by 5.7% to $0.69. The market value of their outstanding shares is at $24.3 million.
• Aileron Therapeutics ALRN stock rose 5.04% to $0.47. The market value of their outstanding shares is at $42.8 million.
• Cidara Therapeutics CDTX shares increased by 5.03% to $0.73. The company's market cap stands at $48.7 million.

Losers

• Veeva Systems VEEV stock decreased by 11.1% to $205.0 during Wednesday's after-market session. The market value of their outstanding shares is at $31.5 billion. As per the news, the Q4 earnings report came out today.
• Stealth BioTherapeutics MITO shares decreased by 6.37% to $0.52. The market value of their outstanding shares is at $29.6 million.
• Cassava Sciences SAVA stock fell 5.96% to $38.2. Cassava Sciences's trading volume hit 61.6K shares by close, accounting for 2.5% of its average volume over the last 100 days. The company's market cap stands at $1.5 billion. As per the news, the Q4 earnings report came out 2 days ago.
• Midatech Pharma MTP stock decreased by 5.95% to $0.95. The market value of their outstanding shares is at $12.0 million.
• Hoth Therapeutics HOTH stock decreased by 5.01% to $0.57. The market value of their outstanding shares is at $13.6 million.
• Singular Genomics Systems OMIC stock decreased by 4.89% to $7.4. The company's market cap stands at $533.2 million. As per the news, the Q4 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.